Acetaminophen/Dextromethorphan Hydrobromide/Chlorphenamine Maleate/Methylephedrine Hydrochloride/Sulfogaiacol/Riboflavin sodium phosphate

对乙酰氨基酚/氢溴酸右美沙芬/马来酸氯苯那敏/盐酸甲基麻黄碱/愈创木酚磺酸钾/核黄素磷酸钠

Report date: 2023/08/09 18:30:04

Base Information

Drug NameAcetaminophen/Dextromethorphan Hydrobromide/Chlorphenamine Maleate/Methylephedrine Hydrochloride/Sulfogaiacol/Riboflavin sodium phosphate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitorsGlutamate [NMDA] receptor antagonistsHistamine H1 receptor antagonists +[4
TargetsCyclooxygenasesGlutamate [NMDA] receptorHistamine H1 receptor +[4
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A